Knowledge hub

AI-powered bioinformatics platform visualizing biological data and model insights in a laboratory setting
Blog

The invisible bridge: How UX design can support AI success in bioinformatics?

Biotech AI data privacy in AI-driven biological and pharmaceutical research
Data Privacy Day 2026: Why Data Privacy Is Becoming a Technical Constraint in Biotech AI
Good AI practice is no longer optional in Drug Discovery – EMA and FDA set the direction
From Public Repositories to Target Hypotheses – An End-to-End Data-to-Insights Journey for scRNA and Spatial Omics with Knowledge Graphs
AI in biotech evolving from experimental models to regulated, production-ready drug discovery systems
AI in Biotech: Lessons from 2025 and the Trends Shaping Drug Discovery in 2026
Fluorescent Cell Painting image showing multiple cellular components used for morphological profiling in drug discovery.
The Applications of Morphological Profiling for Drug Discovery: The success stories
Your monthly AI in biotech digest – December
Leading with purpose: Łukasz Nowak on building strong teams and scalable operations
Leading with purpose: Łukasz Nowak on building strong teams and scalable operations
From patient data to novel targets and biomarkers: UK Biobank use
AI with impact: CTO Michał Warchoł on building tech that matters
From research to impact: Ardigen’s technology behind the Polish Microbiome Map
Your monthly AI in biotech digest – November
Laboratory glassware with digital data visualization overlay, representing the use of public biological datasets for AI-driven drug discovery.
Leveraging Public Datasets for AI-Driven Discovery
Stage view from the SBI² 2025 conference in Boston, showing the event banner and audience.
SBI² 2025 Recap: From Cells to Systems – Imaging, AI, and the Future of Phenotypic Discovery
A Decade of Ardigen
A Decade of Ardigen: Celebrating 10 Years of People, Science & Shared Purpose
AI transformation in clinical trials faces hurdles like data quality, bias, and scalability. Know the challenges and their corresponding sol
Challenges of AI in clinical trials and how to overcome them
New joint study: Computational identification of cross-reactive TCR epitopes with ARDitox